Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nanobiotix Logo
Nanobiotix Growth Score
97
CB Rank
10540
Heat Score
94
Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer.
Founded
obfuscation
PublicPost-IPO Equity Paris, Ile-de-France, France101-250 www.nanobiotix.com
Biotechnology
Health Care
Therapeutics
Overview

Nanobiotix
Total Funding
obfuscation
Growth Score
97
Heat Score
94

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score97
7 pts
in past quarter
Heat Score 94
47 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Nanobiotix

CB Rank
10540
Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer.
Founded
obfuscation
PublicPost-IPO Equity Paris, Ile-de-France, France101-250 www.nanobiotix.com
Biotechnology
Health Care
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Nanobiotix SA
Operating Status Active
Stock Symbol  EPA:NANO
Company Type For Profit
Founders  Laurent Levy
About the Company

Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic

of cancer.

Phone Number +33 1 40 26 04 70
Contact Email contact@nanobiotix.com
Predictions & Insights

Growth Insight

See this Growth Insight
Nanobiotix is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

NBTXR3
A nanoradioenhancer designed to enhance the effect of radiotherapy in treating solid tumors by increasing tumor cell sensitivity to radiation.
Curadigm Nanoprimer Platform
A lipid-based nanoparticle platform designed to temporarily inhibit liver clearance pathways to increase the bioavailability of intravenously administered drugs.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 13
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 13
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nanobiotix Logo
Post-IPO Equity - Nanobiotix
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
HealthCare Royalty Partners Logo
HealthCare Royalty Partners
Yes
Post-IPO Debt - Nanobiotix Logo
Post-IPO Debt - Nanobiotix
—
HealthCare Royalty Partners Logo
HealthCare Royalty Partners
Yes
Post-IPO Debt - Nanobiotix Logo
Post-IPO Debt - Nanobiotix
—
HealthCare Royalty Partners Logo
HealthCare Royalty Partners
Yes
Post-IPO Debt - Nanobiotix Logo
Post-IPO Debt - Nanobiotix
—
HealthCare Royalty Partners Logo
HealthCare Royalty Partners
Yes
Post-IPO Debt - Nanobiotix Logo
Post-IPO Debt - Nanobiotix
—
HealthCare Royalty Partners Logo
HealthCare Royalty Partners
Yes
Post-IPO Debt - Nanobiotix Logo
Post-IPO Debt - Nanobiotix
—
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 6 Contacts 59

Employee Profiles

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

18,985
168.6%
 in past month

IT Spend

$1.2MThis year, Nanobiotix is projected to spend $1.2M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Dow Jones Logo
Dow Jones
75
ASIC Design Logo
ASIC Design
70
ChatGPT Logo
ChatGPT
67

Actively Used Products

19Nanobiotix uses 19 technology products and services including HTML5, DigiCert, and  F5 NGINX, according to G2 Stack.

Active Website Tech Count

29Nanobiotix is actively using 29 technologies for its website, according to BuiltWith. These include IPv6, Gravatar Profiles, and  Common Name Invalid.

Total IP

9Nanobiotix has registered 9 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Nanobiotix's headquarters? Nanobiotix is located in Paris, Ile-de-France, France.Who invested in Nanobiotix? Nanobiotix has 10 investors including HealthCare Royalty Partners and  Johnson & Johnson Innovation.When was the last funding round for Nanobiotix? Nanobiotix closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Nanobiotix's competitors? Alternatives and possible competitors to Nanobiotix may include Canton Strategic Holdings, Lyell Immunopharma, and  EQT Life Sciences.How much funding has Nanobiotix raised to date? Nanobiotix has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|